Department of Surgery, University of Erlangen-Nuremberg, Germany.
J Transl Med. 2010 Sep 6;8:83. doi: 10.1186/1479-5876-8-83.
Accurate histopathological evaluation of resected lymph nodes (LN) is essential for the reliable staging of colorectal carcinomas (CRC). With conventional sectioning and staining techniques usually only parts of the LN are examined which might lead to incorrect tumor staging. A molecular method called OSNA (One Step Nucleic Acid Amplification) may be suitable to determine the metastatic status of the complete LN and therefore improve staging.
OSNA is based on a short homogenisation step and subsequent automated amplification of cytokeratin 19 (CK19) mRNA directly from the sample lysate, with result available in 30-40 minutes. In this study 184 frozen LN from 184 patients with CRC were investigated by both OSNA and histology (Haematoxylin & Eosin staining and CK19 immunohistochemistry), with half of the LN used for each method. Samples with discordant results were further analysed by RT-PCR for CK19 and carcinoembryonic antigen (CEA).
The concordance rate between histology and OSNA was 95.7%. Three LN were histology+/OSNA- and 5 LN histology-/OSNA+. RT-PCR supported the OSNA result in 3 discordant cases, suggesting that metastases were exclusively located in either the tissue analysed by OSNA or the tissue used for histology. If these samples were excluded the concordance was 97.2%, the sensitivity 94.9%, and the specificity 97.9%. Three patients (3%) staged as UICC I or II by routine histopathology were upstaged as LN positive by OSNA. One of these patients developed distant metastases (DMS) during follow up.
OSNA is a new and reliable method for molecular staging of lymphatic metastases in CRC and enables the examination of whole LN. It can be applied as a rapid diagnostic tool to estimate tumour involvement in LN during the staging of CRC.
准确的病理组织学评估切除的淋巴结(LN)对于结直肠癌(CRC)的可靠分期至关重要。由于常规的切片和染色技术通常只能检查 LN 的部分区域,因此可能导致肿瘤分期错误。一种称为 OSNA(一步核酸扩增)的分子方法可能适合确定完整 LN 的转移状态,从而改善分期。
OSNA 基于短时间的均质化步骤和随后从样品裂解物中自动扩增细胞角蛋白 19(CK19)mRNA,结果可在 30-40 分钟内获得。在这项研究中,184 例来自 184 例 CRC 患者的冷冻 LN 通过 OSNA 和组织学(苏木精和伊红染色和 CK19 免疫组织化学)进行了检测,每种方法使用一半的 LN。对结果不一致的样本进一步通过 CK19 和癌胚抗原(CEA)的 RT-PCR 进行分析。
组织学和 OSNA 之间的一致性率为 95.7%。3 个 LN 组织学+/OSNA-,5 个 LN 组织学-/OSNA+。在 3 个不一致的病例中,RT-PCR 支持 OSNA 结果,提示转移仅位于 OSNA 分析的组织或用于组织学的组织中。如果排除这些样本,一致性为 97.2%,敏感性为 94.9%,特异性为 97.9%。3 名(3%)患者根据常规组织病理学分期为 UICC I 或 II 期,通过 OSNA 分期为 LN 阳性。其中一名患者在随访期间出现远处转移(DMS)。
OSNA 是一种用于 CRC 淋巴转移分子分期的新的可靠方法,可用于检查整个 LN。它可以作为一种快速诊断工具,用于估计 CRC 分期时 LN 中的肿瘤受累情况。